Telemedicine reshaped how med spas and wellness practices operate, remote good-faith exams, virtual consults, and remote prescribing became routine. But the rules underpinning remote prescribing are approaching a hard deadline, and practices that built their model on the current flexibilities need to pay attention.
The background: during the pandemic, the DEA temporarily allowed practitioners to prescribe controlled substances via telemedicine without a prior in-person visit. Those flexibilities have been extended, currently through December 31, 2026, but they are temporary, and permanent rules are expected. When they land, the framework for remote controlled-substance prescribing could look meaningfully different.
For med spas, the first thing to understand is what this does and does not touch. GLP-1 medications like semaglutide and tirzepatide are not controlled substances, so they do not require DEA registration and are not governed by these specific controlled-substance telemedicine rules. But many practices offer services that do involve controlled substances, or are moving toward them, and those are directly in scope.
The second thing: telemedicine prescribing is never governed by federal rules alone. States impose their own requirements, and when state and federal rules differ, the stricter one governs. Many states require a synchronous, real-time audio-video encounter to establish the patient relationship; a questionnaire or asynchronous intake is not enough. Some states also mandate prescription-monitoring-program checks and specific documentation. A practice can be compliant federally and still violate state law.
The good-faith exam sits at the center of all of this. Whether performed in person or by compliant telemedicine, it must meet the standard of care, real evaluation, appropriate history, and a documented order. Regulators have specifically targeted 'questionnaire medicine,' prescribing off a brief online form without a genuine encounter.
What should practices do now? Map which of your services involve controlled substances. Confirm your telemedicine workflow meets both federal and your state's requirements, especially the synchronous-encounter standard. Watch the December 31, 2026 deadline and the permanent rules that follow. And make sure your coverage reflects a telemedicine-based model.
In over 25 years in this industry, the practices that navigate regulatory transitions best are the ones tracking them in advance rather than reacting after the rule changes.
Telemedicine is a powerful tool for modern practices. Just make sure the framework you built on is one you can still stand on next year.
If your practice prescribes via telemedicine, your compliance and your coverage both need to keep up with changing rules. We specialize in insuring modern, telemedicine-enabled practices, with over 25 years of experience. Check your eligibility and make sure your model is protected.
Check Your EligibilityWhen do the DEA telemedicine prescribing flexibilities expire?
The temporary DEA flexibilities allowing controlled-substance prescribing via telemedicine without a prior in-person visit are currently extended through December 31, 2026. Permanent rules are expected and may change the framework.
Do telemedicine rules affect GLP-1 prescribing?
Not the controlled-substance rules specifically, because GLP-1 medications are not controlled substances. However, state telemedicine and good-faith-exam requirements still apply to GLP-1 prescribing.
Can I prescribe based on an online questionnaire?
Generally no. Many states require a synchronous, real-time audio-video encounter to establish the patient relationship. Regulators have specifically targeted 'questionnaire medicine.' When state and federal rules differ, the stricter governs.
What should my practice do about telemedicine prescribing rules?
Map which services involve controlled substances, confirm your workflow meets both federal and state requirements (especially the synchronous-encounter standard), monitor the December 31, 2026 deadline, and ensure your coverage reflects a telemedicine model.
[[YULIA_DISCLAIMER]]
Prescribing via telemedicine and unsure your model still holds up? Schedule a free consultation. We will review your setup and make sure your coverage fits how you actually practice.
Schedule a Free Consultation